In the cohort analysis by Siddeeque et al., a trend toward reduced PD risk was observed among GLP-1 RA users, but the association did not reach statistical significance [ 82 ].
← all excerpts
Beyond Glycemic Control: GLP-1RA-Based Therapies and Emerging Targets Beyond the Metabolic Axis.
1
—
—